Navigation Links
InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry. InspireMD Will Also Sponsor a Satellite Program Breakfast Meeting at the TCT Conference on September 24th 2009 in the Moscone Exhibition Center in San Francisco
Date:9/23/2009

SAN FRANCISCO, September 23 /PRNewswire/ -- InspireMD, developers of MGuard(TM), announced today that the first patient has been enrolled in the Israeli MGuard(TM) Registry. MGuard(TM) was successfully implanted in Natanya, Israel, at the Laniado Hospital Cath Lab, managed by Dr. Yitzhak Herz, the principal investigator for the Registry at this hospital.

The Israeli MGuard Registry will enroll 100 'real world' MGuard patients from eight hospitals in Israel. Data from the registry will be used to support data from other MGuard clinical studies.

The first MGuard Stent in the Israeli MGuard Registry was implanted by Dr. Guy Schoenmann from the Laniado Hospital in Netanya. The patient was a 70 year old male treated for myocardial infarction (MI) caused by a thrombus occluding the right coronary artery. Dr. Schoenmann stated: "MGuard(TM) was delivered with no complications and it immediately enabled excellent flow in the artery. We experienced a very successful procedure and I am very pleased that MGuard is now available to us on daily basis".

Mr. Eli Bar CTO and VP R&D stated: "Currently MGuard is mostly used in AMI, SVG, and thrombus containing lesions. The Israeli MGuard registry is very important for us in order to understand the clinical performance of MGuard in the 'real world' and receive a wider perspective on its use in special patient subgroups".

On September 24th 2009, InspireMD will Sponsor a Breakfast Meeting at the TCT Conference 2009 in San Francisco, Titled "The Role of the MGuard(TM) Stent in Thrombus Management During AMI Interventions". The meeting chairman will be Dr. Martin B. Leon , the Chairman of the CRF, NY; Associate Director at New York Presbyterian Hospital and Professor at Columbia University Medical Center NY. InspireMD's Breakfast Meeting faculty will include Alexandre Abizaid, MD, PhD, Antonio Colombo, MD, Peter J. Fitzgerald, MD, PhD,
'/>"/>

SOURCE InspireMD
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR 09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le
2. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
3. InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
4. MedShape Solutions, Inc. Announces First FDA-cleared Shape Memory PEEK Device; Closing of $10M Equity Offering
5. XRC Medical Imaging Announces Rapid Test Results
6. Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference
7. Boston Scientific Announces Release of Next-Generation iLab(R) System Software
8. Brennen Medical Announces Sale of XenMatrix(R)
9. PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long-Acting Growth Hormone
10. AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS-112 in Cancer
11. Halocarbon Announces Licensing Agreement with IBM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... November 17, 2014 Athena Signature Series: Turning ... Dr. Beverly Emerson, a professor in the Regulatory Biology Laboratory ... most recent discovery points to an “off switch” for drug ... and how her local research is making a global impact ... findings and then join host Cheryl K. Goodman, CEO of ...
(Date:11/18/2014)... FL (PRWEB) November 18, 2014 Brothers ... announced the launch of PAWSitively Curing Cancer, Inc ... This new 501(c) (3) non-profit organization is dedicated to ... donated goes directly to the University of Florida ... partner with PAWSitively Curing Cancer as the recipient of ...
(Date:11/18/2014)... INCLINE VILLAGE, Nev. , Nov. 18, 2014 /PRNewswire/ ... ) today announced that in connection with the acquisition ... approximately $42.7 million in connection with the termination of ... the full principal amount outstanding of $40 million, accrued ... October 2013, PDL entered into a structured financing transaction ...
(Date:11/18/2014)... 2014  Novira Therapeutics, Inc., a privately held biopharmaceutical ... hepatitis B virus (HBV) infection, today announced that ... Scientific Advisory Board (SAB).  "We are ... Christian S. Schade , Chief Executive Officer of Novira.  ... will be invaluable to Novira as our lead core ...
Breaking Biology Technology:PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 2PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 3PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3
... necessary for making a highly potent and clinically unexploited ... are antibiotic molecules produced by soil bacteria, and we ... which is active against many different pathogens," said Professor ... the paper to be published in PNAS. "Our ...
... are using the engineering technology behind the creation ... for the replacement of delicate and complex facial ... The researchers, combining engineering and plastic surgery ... optimization to design an experimental 3-D structure that ...
... July 12 /PRNewswire/ - Ocean Nutrition Canada (ONC) supplier ... supplement ingredients, announces today the acquisition of the exclusive global marketing ... , , , ... result of the agreement, ONC acquired the rights to exclusive use ...
Cached Biology Technology:Key milestone towards the development of a new clinically useful antibiotic 2High-performance engineering used to design facial bone replacements 2High-performance engineering used to design facial bone replacements 3Ocean Nutrition Canada Announces Acquisition of Exclusive License to GAT Food Essentials, Omega-3 Microencapsulation-Emulsion Technology 2Ocean Nutrition Canada Announces Acquisition of Exclusive License to GAT Food Essentials, Omega-3 Microencapsulation-Emulsion Technology 3
(Date:11/18/2014)... WASHINGTON , Nov. 18, 2014  The ... Security Industry Association today jointly announce the formation ... and release of its Identity and Biometric ... (Framework). The Framework received official support from BORDERPOL, ... governments to improve and provide expertise regarding border ...
(Date:11/18/2014)... Md. , Nov. 17, 2014 The Parenteral ... and U.S. regulatory agencies will speak and at least seven ... Metrics Conference at the Omni Shoreham Hotel in ... pleased once again to have significant support from the regulatory ... Europe in our effort to help ...
(Date:11/15/2014)... we may still be a few years away from the ... gain instant access to all that ailed his patients, mobile ... for monitoring and measuring our health are cropping up in ... tad Orwellian to some, but a new survey suggests that ... into their healthcare regime. These are some of ...
Breaking Biology News(10 mins):Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4
... BEER-SHEVA, ISRAEL, February 17, 2011 Robotics researchers at ... million grant (977,840 ) to develop intelligent sensing and ... high value crops. The project is part of ... Robots for Crops). cRops will develop the scientific ...
... for the Advancement of Science (AAAS) has named Dr. ... the University of Colorado School of Medicine, as winner ... Technology Award., Cohen was honored for his outstanding achievements ... a series of free lectures on science and medicine, ...
... Four newly named beneficiaries of the Joshua E. ... new stem cell transplantation technology, the macroeconomics of ... The award recipients will receive partial financial support ... 2011 Annual Meeting of the American Association for ...
Cached Biology News:Ben-Gurion U. part of EU consortium to develop robots that selectively pick fruit 2Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 2Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 3Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 4Joshua E. Neimark Memorial Travel Assistance Award winners investigate stem cell transplantation, sustainable growth, women in academia, and conservation science 2Joshua E. Neimark Memorial Travel Assistance Award winners investigate stem cell transplantation, sustainable growth, women in academia, and conservation science 3
Request Info...
... Immunogen KLH-conjugated, synthetic ... 47-66 (PAEV-GPGAVGERTPRKKEPP) of human BRAF-HDAC ... (BHC110/LSD1). Quality Assurance ... Stability 2 years ...
Adducin beta (C-16)...
Geneticin Selective Antibiotic liquid...
Biology Products: